Audentes Therapeutics To Present At The Leerink Partners Rare Disease Roundtable

Audentes Therapeutics, Inc., a private biotechnology company dedicated to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced that Matthew Patterson, President and Chief Executive Officer, will present a corporate overview at the Leerink Partners Rare Disease Roundtable in New York City on October 1, 2014.

Help employers find you! Check out all the jobs and post your resume.